Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

INVADERS

Financiado

Cerrado

Mucus Penetrating Microbiota Characterization Mechanism and Therapeutic in Met...

Mucus Penetrating Microbiota Characterization Mechanism and Therapeutic in Metabolic Disease Mucus-Penetrating Microbiota: Characterization, Mechanism and Therapeutic in Metabolic Disease Humanity is facing an epidemic of inter-related metabolic disorders, including obesity, insulin resistance, hyperglycemia, hyperlipide... ver más

30/09/2024

INSERM

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHER... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2024-09-30

ERC-2018-STG: ERC Starting Grant

I+D

Cerrada hace 7 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

INSERM

1.85M€ | Lider

INNOVATI SERVICIOS TECNOLOGI...

244.04K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

Microbes4U Study of the therapeutic potential of an Akkermansia mucinip... 149K€ Cerrado

MEDMOTILUS Metabolic diseases from the point of view of the gut bacteri... 185K€ Cerrado

PID2019-110063RA-I00 EFICACIA DE UNA ESTRATEGIA DE EDUCACION NUTRICIONAL Y EL ROL... 36K€ Cerrado

PCI2018-093245 OBESIDAD Y DIABETES EN IBEROAMERICA: FACTORES DE RIESGO Y NU... 88K€ Cerrado

Mucus and Metabolism The relationship between the intestinal mucosal barrier and... 198K€ Cerrado

Drug the bug Identification of novel inhibitors to prevent microbial prod... 150K€ Cerrado

Duración del proyecto: 63 meses Fecha Inicio: 2019-06-19
Fecha Fin: 2024-09-30

Líder del proyecto

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHER... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Mucus-Penetrating Microbiota: Characterization, Mechanism and Therapeutic in Metabolic Disease Humanity is facing an epidemic of inter-related metabolic disorders, including obesity, insulin resistance, hyperglycemia, hyperlipidemia, and hepatic steatosis, that altogether have major impact on the promotion of cardiovascular diseases. The increasing incidence of these complex metabolic disorders and their highly morbid, chronic and costly downstream diseases threatens to overwhelm the world’s health care systems and economies, making it a top public health priority in dire need of investigation. The intestinal tract is inhabited by a large and diverse community of bacteria, collectively referred to as the intestinal microbiota. When stably maintained at an appropriately safe distance from the epithelial cell monolayer, the microbiota provides important benefits to its host. However, disturbance of the microbiota-host relationship, promoted by genetic or non-genetic factors, can alter intestinal homeostasis and drive chronic low-grade intestinal inflammation, ultimately leading to metabolic abnormalities. We previously reported that a ubiquitous class of food additives, emulsifiers, detrimentally impact the microbiota resulting in its encroachment into the mucus layer that associated with low-grade inflammation and development of metabolic disorders. The central goal of this proposal is to investigate the hypothesis that bacteria that penetrate the inner part of the mucus layer, referred as invaders, promote development of metabolic alterations. We herein propose to identify mucus-invaders, in preclinical models and clinical conditions, and investigate mechanisms by which they promote inflammatory and metabolic abnormalities. Furthermore, we propose to define original approaches to modulate the intestinal microbiota in order to counteract microbiota encroachment and protect against associated metabolic abnormalities.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores